The authoritative guide to ensuring science and technology make life on Earth better, not worse.

Iran

Passengers wait for the train with masks on.

Iran’s coronavirus response: A lesson in what not to do

By Vahid Yücesoy | Biosecurity

Emmanuel Macron with Donald Trump at the G7 summit in August 2019

Avoiding the clash over the Iran arms embargo: How Europe can square the circle

By Ellie Geranmayeh | Nuclear Risk

Qased rocket before launch

Iran’s space launches are not a cover for missile work. Until they are.

By John Krzyzaniak | Nuclear Risk

Rafael Mariano Grossi

Coronavirus and the IAEA reports: From maximum pressure to humanitarian détente with Iran

By Robert J. Goldston | Nuclear Risk, Opinion

Joe Biden, 2020.

How Joe Biden’s statement falls short on calling for Iran sanctions relief

By John Krzyzaniak | Nuclear Risk

IAEA nuclear safeguards inspectors with remote surveillance equipment

Round-the-clock surveillance of Iran’s uranium-enrichment sites continues, despite coronavirus

By Tariq Rauf | Nuclear Weapons, Special Topics

Sen. Tom Cotton at a congressional hearing.

Why do politicians keep breathing life into the false conspiracy theory that the coronavirus is a bioweapon?

By Matt Field, John Krzyzaniak | Biosecurity

Libya centrifuges

Interview: “Delaying Doomsday” author explains how to stop nuclear proliferation

By John Krzyzaniak | Interviews, Nuclear Risk

UN Security Council meeting

The US has a backup plan to kill the Iran nuclear deal. It could spark a crisis at the UN.

By Julia Masterson, Samuel M. Hickey | Analysis, Nuclear Risk

Mohammad Javad Zarif, in 2019

Iran’s impending exit from the NPT: A new nuclear crisis

By Kaveh L. Afrasiabi, Nader Entessar | Nuclear Risk, Opinion

Donald Trump and Qassem Soleimani.

The Soleimani killing and 5 things to know about drones in Iraq

By Dan Gettinger | Disruptive Technologies

Cover of Iranian newspaper

No, Iran didn’t exit the nuclear deal. And no, its nuclear announcement is not revenge for Soleimani.

By John Krzyzaniak | Nuclear Risk